Skip to content

COGT

Cogent Biosciences, Inc.

Stock

$31.02−0.57 (−1.80%)Close Oct 2, 2026

Free cash flow, 2025
−$266M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$266M—
2024−$208M—
2023−$156M—
2022−$126M—
2021−$60M—
2019−$42M—
2018−$33M—
2017−$27M—